If you are thinking of taking testosterone drugs to boost your libido, you’d better be aware of the increased risks of heart attack or stroke, a federal agency warned.
The Food and Drug Administration is requiring manufacturers of testosterone replacement medicines to update their label to take into account new safety warnings. The decision, announced Tuesday, follows concerns from agency advisers last year about the risks of these medicines.
Testosterone replacement therapies are only supposed to be for men who have low testosterone due to a medical condition such as diabetes. However, the agency found that healthy men with low testosterone levels due to aging are also using the drugs.
Testosterone replacement products have grown into a huge market, especially with an aging U.S. population. Testosterone products have generated billions in sales, with Abbvie’s Androgel leading the charge, with $1 billion in 2013.